CLINICAL-TRIAL ADRIAMYCIN (NSC-123127) IN ADVANCED SARCOMAS

被引：27

作者：

CREAGAN, ET ^{[1
]}

HAHN, RG ^{[1
]}

AHMANN, DL ^{[1
]}

BISEL, HF ^{[1
]}

机构：

[1] MAYO CLIN & MAYO FDN,DIV MED ONCOL,ROCHESTER,MN 55901

来源：

ONCOLOGY | 1977年 / 34卷 / 02期

关键词：

D O I：

10.1159/000225192

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：90 / 91

页数：2

共 9 条

[1]

BENJAMIN RS, 1974, CANCER, V33, P19, DOI 10.1002/1097-0142(197401)33:1<19::AID-CNCR2820330107>3.0.CO

[2]

2-M

[3] ADRIAMYCIN - NEW ANTICANCER DRUG WITH SIGNIFICANT CLINICAL ACTIVITY [J].

BLUM, RH ;

CARTER, SK .

ANNALS OF INTERNAL MEDICINE, 1974, 80 (02) :249-259

[4] ADRIAMYCIN - REVIEW [J].

CARTER, SK .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1975, 55 (06) :1265-1274

[5] AMPUTATION AND ADRIAMYCIN IN PRIMARY OSTEOSARCOMA [J].

CORTES, EP ;

HOLLAND, JF ;

WANG, JJ ;

SINKS, LF ;

BLOM, J ;

SENN, H ;

BANK, A ;

GLIDEWELL, O .

NEW ENGLAND JOURNAL OF MEDICINE, 1974, 291 (19) :998-1000

[6]

MIDDLEMAN E, 1971, CANCER-AM CANCER SOC, V28, P844, DOI 10.1002/1097-0142(1971)28:4<844::AID-CNCR2820280407>3.0.CO

[7]

2-9

[8]

OBRYAN RM, 1973, CANCER-AM CANCER SOC, V32, P1, DOI 10.1002/1097-0142(197307)32:1<1::AID-CNCR2820320101>3.0.CO

[9]

2-X

← 1 →